305 related articles for article (PubMed ID: 19509016)
1. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.
Ding Y; Xu D; Feng G; Bushell A; Muschel RJ; Wood KJ
Diabetes; 2009 Aug; 58(8):1797-806. PubMed ID: 19509016
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
Ding Y; Bushell A; Wood KJ
Transplantation; 2010 Feb; 89(3):270-3. PubMed ID: 20145515
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.
Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ
Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122
[TBL] [Abstract][Full Text] [Related]
4. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
Ben Nasr M; Vergani A; Avruch J; Liu L; Kefaloyianni E; D'Addio F; Tezza S; Corradi D; Bassi R; Valderrama-Vasquez A; Usuelli V; Kim J; Azzi J; El Essawy B; Markmann J; Abdi R; Fiorina P
Acta Diabetol; 2015 Oct; 52(5):917-27. PubMed ID: 25808641
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation.
Reading JL; Sabbah S; Busch S; Tree TI
Curr Opin Organ Transplant; 2013 Feb; 18(1):59-64. PubMed ID: 23222174
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor-β Partially Reversed the Immunosuppressive Effect of Mesenchymal Stem Cells in Mice.
Zhao J; Qi YJ; Wang X; Jiao Y; Gong HM; Zhang JX; Jiang DY
Transplant Proc; 2018 Dec; 50(10):3851-3857. PubMed ID: 30577277
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of allogeneic bone marrow-derived mesenchymal stromal cells on aortic aneurysms.
Akita N; Narita Y; Yamawaki-Ogata A; Usui A; Komori K
Cell Tissue Res; 2021 Feb; 383(2):781-793. PubMed ID: 33146827
[TBL] [Abstract][Full Text] [Related]
9. Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts.
Jacobson S; Kumagai-Braesch M; Tibell A; Svensson M; Flodström-Tullberg M
Ann N Y Acad Sci; 2008 Dec; 1150():213-6. PubMed ID: 19120298
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice.
Xu DM; Yu XF; Zhang D; Zhang MX; Zhou JF; Tan PH; Ding YC
Diabetologia; 2012 Apr; 55(4):1091-102. PubMed ID: 22270222
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
[TBL] [Abstract][Full Text] [Related]
12. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.
Nauta AJ; Westerhuis G; Kruisselbrink AB; Lurvink EG; Willemze R; Fibbe WE
Blood; 2006 Sep; 108(6):2114-20. PubMed ID: 16690970
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
Mielcarek M; Storb R; Georges GE; Golubev L; Nikitine A; Hwang B; Nash RA; Torok-Storb B
Biol Blood Marrow Transplant; 2011 Feb; 17(2):214-25. PubMed ID: 20816818
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
[TBL] [Abstract][Full Text] [Related]
15. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.
Ge W; Jiang J; Baroja ML; Arp J; Zassoko R; Liu W; Bartholomew A; Garcia B; Wang H
Am J Transplant; 2009 Aug; 9(8):1760-72. PubMed ID: 19563344
[TBL] [Abstract][Full Text] [Related]
16. Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice.
Treacy O; Lynch K; Murphy N; Chen X; Donohoe E; Canning A; Lohan P; Shaw G; Fahy G; Ryan AE; Ritter T
Stem Cell Res Ther; 2021 Apr; 12(1):227. PubMed ID: 33823917
[TBL] [Abstract][Full Text] [Related]
17. Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.
Casiraghi F; Todeschini M; Azzollini N; Cravedi P; Cassis P; Solini S; Fiori S; Rota C; Karachi A; Carrara C; Noris M; Perico N; Remuzzi G
Transplantation; 2019 Jun; 103(6):1121-1130. PubMed ID: 30801518
[TBL] [Abstract][Full Text] [Related]
18. Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor α (CD25) cleavage by producing matrix metalloproteinases.
Park MJ; Shin JS; Kim YH; Hong SH; Yang SH; Shin JY; Kim SY; Kim B; Kim JS; Park CG
Stem Cell Rev Rep; 2011 Jun; 7(2):381-93. PubMed ID: 21103959
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
